National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 99,646 cases where Vaccine targets Shingles (VARZOS) and Submission Date on/before '2018-05-31'

Government Disclaimer on use of this data



Case Details

This is page 10 out of 9,965

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next


VAERS ID: 267073 (history)  
Form: Version 1.0  
Age: 66.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2006-10-26
Onset:2006-10-26
   Days after vaccination:0
Submitted: 2006-11-14
   Days after onset:19
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER U2273A / UNK UN / UN
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0622F / 1 UN / SC

Administered by: Private       Purchased by: Other
Symptoms: Aphonia, Pruritus, Rash, Reaction to previous exposure to any vaccine, Varicella post vaccine
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CLONOPIN, SINGULAIR, REQUIP
Current Illness:
Preexisting Conditions: Asthma, restless legs syndrome, allergic reaction to antibiotics
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type: WAES0610USA14575

Write-up: Information has been received from a 66 year old female with asthma, restless legs syndrome, and an allergy to an unspecified antibiotic who on 26-OCT-2006 was vaccinated SC with a 0.5 mL dose of ZOSTAVAX. Concomitant vaccination at the same time included a dose of influenza virus vaccine (unspecified). Other concomitant medication included montelukast sodium (MSD), clonazepam (CLONOPIN), and ropinirole hydrochloride (REQUIP). on 26-OCT-2006, nine hours after vaccination, the patient began to itch all over. She was treated with cetirizine hydrochloride (ZYRTEC), but continued to itch all over. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested. 6/17/10 Additional informationi has been received from the patient''s physician who reported that on 27-OCT-2006, the patient had puritis and a rash and went to the emergency room. The patient recovered on 29-OCT-2006. Medical records revealed that the patient was admitted to the emergency room on 27-OCT-2006 at 19:38 PM. The complaint was reaction to shingles vaccine, rash, itch and voic going. It was noted that the patient had a history of high cholesterol and hypothyroidism. The patient took 40 mg of prednisone and at 20:00 PM no rash was noted. She was alert and oriented, her speech was clear, and no shortness of breath was noted. The clinical impression was that she had an acute allergic reaction to varicella-zoster virus vaccine live ZOSTAVAX (Merck). The patient departed the emergency room at 21:40 PM. Additional information is not expected.


VAERS ID: 267074 (history)  
Form: Version 1.0  
Age: 62.0  
Sex: Male  
Location: Colorado  
Vaccinated:2006-09-14
Onset:2006-09-14
   Days after vaccination:0
Submitted: 2006-11-14
   Days after onset:61
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Cerebrovascular accident, Eye disorder, Transient ischaemic attack
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Corneal disorders (broad), Retinal disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA15191

Write-up: Information has been received from a physician concerning a 62 year old male who on 9/14/06 was vaccinated with a dose of Varicella Zoster vaccine. On 9/14/06, following vaccination, the pt experienced right eye transient ischemic attack (mini stroke). A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 11/14/2006. Information has been received from a physician concerning a 62 year old male who on 14-SEP-2006 was vaccinated with a dose of ZOSTAVAX (Merck). ON 14-SEP-2006, following vaccination, the patient experienced right eye transient ischemic attack (TIA). A product quality complaint was not involved. Additional information has been received from the physician who reported that the patient was at risk of TIA, however, he had not previously experienced one. The physician reported that he would have more diagnostic information in the future, including an MRI, echocardiogram, carotid ultrasound, and cardiovascular workup which may allow better understanding of the stroke pathway. Additional information has been requested. This is in follow-up to report(s) previously submitted on 11/14/2006; 12/20/2006. Information has been received from a physician concerning a 62 year old male who on 14-SEP-2006 was vaccinated with a dose of ZOSTAVAX (Merck). On 14-SEP-2006 following vaccination, the patient experienced right eye transient ischemic attack. A product quality complaint was not involved. Additional information has been received from the physician who reported that the patient was at risk for TIA, however, he had not previously experienced one. The physician reported that he would have more diagnostic information in the future, including an MRI, echocardiogram, carotid ultrasound, and cardiovascular workup which may allow better understanding of the stroke pathway. Additonal information has been received from the physician''s office. It was reported that the patient had just recently had his MRI approved by his insurance company. The physician will provide the results when the MRI occurs. Additional information has been requested.


VAERS ID: 267075 (history)  
Form: Version 1.0  
Age: 62.0  
Sex: Female  
Location: California  
Vaccinated:2006-10-12
Onset:2006-10-28
   Days after vaccination:16
Submitted: 2006-11-14
   Days after onset:17
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0722F / UNK UN / SC

Administered by: Other       Purchased by: Other
Symptoms: Blister, Lip ulceration
SMQs:, Severe cutaneous adverse reactions (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vagifem, Temazapam
Current Illness:
Preexisting Conditions: Breast cancer, Drug hypersensitivity.
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type: WAES0611USA00570

Write-up: Information has been received from a physician concerning a 62 year old female with a codeine allergy and a history of breast cancer 8 years ago, who on 10/12/06 was vaccinated SC in the arm with a 0.65ml dose of Varicella Zoster vaccine (lot 652966/0722F). Concomitant therapy included Vagifem. Concomitant vaccination included a dose of Influenza vaccine (unspec) given in the other arm on the same day. On 10/28/2006 the pt experienced fever blisters or cold sores on her lips. The pt was seen by a physician on 10/30/06, no lab or diagnostic test were performed. At the time of this report the pt had not recovered. no product quality complaint was involved. Additional information has been requested.


VAERS ID: 267076 (history)  
Form: Version 1.0  
Age: 4.0  
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2006-10-28
Submitted: 2006-11-14
   Days after onset:17
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Infection transmission via personal contact, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0611USA00724

Write-up: Information has been received from a consumer concerning her 4 year old grandson who developed a fever and a rash after the reporter was vaccinated on 11/26/06 with a 0.65ml dose of varicella zoster vaccine. The reporter, who has no allergies, a history of pancreas cancer, and was on no concomitant medication, indicated that on the date of her vaccination, she saw her grandson later in the afternoon as well as several days after. On 10/28/06 her grandson woke up with a fever and as of 10/31/06 he developed a rash on his face and front and back above the waist. A product complaint was not involved. Additional information has been requested.


VAERS ID: 267047 (history)  
Form: Version 1.0  
Age: 66.0  
Sex: Female  
Location: California  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2006-11-16
Entered: 2006-11-17
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0981F / 1 RA / -

Administered by: Private       Purchased by: Private
Symptoms: Headache, Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Pruritus
SMQs:, Anaphylactic reaction (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Right arm swollen, itchy, red, painful, headache


VAERS ID: 267077 (history)  
Form: Version 1.0  
Age: 67.0  
Sex: Female  
Location: California  
Vaccinated:2006-10-25
Onset:2006-11-03
   Days after vaccination:9
Submitted: 2006-11-13
   Days after onset:10
Entered: 2006-11-17
   Days after submission:4
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Drug ineffective, Pruritus, Pyrexia, Skin ulcer, Viral infection
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temp 99.4 deg F 11/03/2006.
CDC Split Type: WAES0611USA03069

Write-up: Information has been received from a physician concerning a 67 year old female who on approximately 25-Oct-2006 was vaccinated with a dose of varicella-zoster virus vaccine live. On 03-Nov-2006, the patient developed acute varicella characterized by pruritic lesions on her chest and a low-grade fever of 99.4 degrees Fahrenheit. Unspecified medical attention was sought and the patient was being treated with valacyclovir hydrochloride (VALTREX) 1 gm TID. A product quality complaint was not involved. Acute varicella was considered to be an other important medical event by the physician. Additional information has been requested. (OMIC)


VAERS ID: 267097 (history)  
Form: Version 1.0  
Age: 86.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2006-10-06
Onset:2006-11-02
   Days after vaccination:27
Submitted: 2006-11-08
   Days after onset:6
Entered: 2006-11-17
   Days after submission:9
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0981F / UNK - / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Herpes zoster
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: History of breast and colon cancer remotely, not immune suppressed.
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: This 86 year old woman was given a Zostavax on 10/06/2006. On 11/02/2006 she developed herpes zoster of the first division of the fifth cranial nerve, fortunately without eye involvement. (OMIC) She did have an episode of zoster - not due to flu vaccine & did better than expected due to the vaccine


VAERS ID: 267208 (history)  
Form: Version 1.0  
Age: 60.0  
Sex: Female  
Location: California  
Vaccinated:2006-11-14
Onset:2006-11-15
   Days after vaccination:1
Submitted: 2006-11-16
   Days after onset:1
Entered: 2006-11-17
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / 1 LA / -

Administered by: Public       Purchased by: Public
Symptoms: Injection site erythema, Injection site induration, Injection site pain
SMQs:, Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Evista 60mg
Current Illness: NONE
Preexisting Conditions: Osteopenia
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type:

Write-up: 11/14/06 830AM Zostavax SQ LA. Approximately 24 hours later, injection site was firm 1"x1" oblong, tender. 11/15/06 Noticed tender and firmarca at injection site. 11/16/06 5PM Injection site measures 60mmx20mm - red, hot to touch, firmarca 30mmx18mm and darker red. ? Blister.


VAERS ID: 267508 (history)  
Form: Version 1.0  
Age: 60.0  
Sex: Female  
Location: California  
Vaccinated:2006-10-27
Onset:2006-11-08
   Days after vaccination:12
Submitted: 2006-11-17
   Days after onset:9
Entered: 2006-11-21
   Days after submission:4
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PPV: PNEUMO (PNEUMOVAX) / MERCK & CO. INC. 1008P / 1 LA / IM
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0981F / 1 RA / SC

Administered by: Private       Purchased by: Other
Symptoms: Pruritus, Rash papular, Shoulder pain
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (broad), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE known
Allergies:
Diagnostic Lab Data: Response to NEURONTIN Unknown
CDC Split Type: WAES0511USA04261

Write-up: Pain along left scapula into shoulder beginning 2 days after vaccine and then out break papular rash with pain/itch pain relieved with NEURONTIN. This is in follow-up to report(s) previously submitted on 12/14/2006. Information has been received from a physician concerning a 60 year old female with no known allergies or medical conditions who on 27-OCT-2006 in the AM was vaccinated SC in the right arm with a 0.65 mL first dose of VARIVAX (Merck) (lot # 652936/0981F). Concomitant vaccination on the same day included a first IM dose in the left deltoid of PNEUMOVAX (lot # 651320/1008P). There were no other concomitant vaccinations. There was no illness at the time of vaccination. After vaccination, on approximately 06-NOV-2006, the patient developed an atypical shingles rash with pain. Unspecified medical attention was sought and the patient was treated with NEURONTIN for the pain. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been received from the physician who reported that on 06-NOV-2006 the patient had pain along the left scapula into the shoulder beginning "two days after the vaccine" and then an outbreak of a papular rash with pain and itching. The pain was relieved with NEURONTIN. At the time of the report, the patient was recovering. No further information is expected.


VAERS ID: 267589 (history)  
Form: Version 1.0  
Age: 61.0  
Sex: Female  
Location: Illinois  
Vaccinated:2006-11-03
Onset:2006-11-18
   Days after vaccination:15
Submitted: 2006-11-21
   Days after onset:3
Entered: 2006-11-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0621F / 1 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Herpes zoster
SMQs:, Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Herpes Zoster, Valtrex


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=10&VAX=VARZOS&VAXTYPES=Shingles&SUB_YEAR_HIGH=2018&SUB_MONTH_HIGH=05


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166